The FDC of MSP could be a good armamentarium for physicians to manage Indian patients with T2DM characterized by insulin resistance that is not controlled by dual therapy, as well as for those with uncontrolled diabetes who are reluctant to take insulin. Here, INS is linked to type 2 diabetes mellitus.